Neutrogena Apologizes for Dropping Hayden Panettiere After Postpartum Depression Disclosure

Key points

• Neutrogena stated on Instagram that it is 'deeply saddened' by Panettiere’s passing and acknowledged that it made her feel unsupported during a difficult time.
• The company admitted that its decision not to renew Panettiere’s contract was not aligned with its values, calling her public disclosure of mental health struggles 'courageous.'
• Neutrogena announced a 'significant investment' in an unnamed community health partner to improve access to care for postpartum depression, though specific details were withheld.
• The statement was delayed by three days after Panettiere’s death, with the company citing respect for her family as the reason for the silence.
• Panettiere’s 2026 memoir, 'This Is Me: A Reckoning,' and a May 2026 podcast interview detailed her claim that Neutrogena invoked a morality clause to end their decade-long partnership after she discussed postpartum depression on 'Live! with Kelly and Michael' in 2015.

Background

This controversy resurfaced following Hayden Panettiere’s death on August 17, 2026, at age 36. Prior to her passing, fans had already begun calling for a boycott after her memoir and podcast appearances detailed the brand’s decision to drop her. Neutrogena had remained silent during the initial wave of backlash in May and early August, leading to growing public scrutiny. The brand’s partnership with Panettiere lasted from 2005 to 2015, during which she served as a global ambassador. The current incident highlights ongoing tensions between corporate image management and the personal struggles of celebrity endorsers, particularly regarding mental health stigma.

How outlets are covering it

ABC News and The Hollywood Reporter focused on the content of Neutrogena’s official statement, emphasizing the company’s admission that it made Panettiere feel unsupported and its pledge to invest in mental health support. CBC News highlighted the consumer reaction, noting that fans had been demanding a response for months and that the apology came only after the actress’s death intensified the backlash. Page Six provided detailed context from Panettiere’s memoir, quoting her description of the contract cancellation as a 'blow' that damaged her career and her sense of professionalism. While all outlets agree on the facts of the apology, they differ in emphasis: ABC and THR present the corporate response as a resolution, while CBC and Page Six frame it as a reactive measure to sustained public pressure and boycott efforts.

Why it matters

This incident underscores the growing public expectation for brands to take responsibility for how they treat celebrity endorsers, particularly when those endorsers speak out about mental health issues. The backlash against Neutrogena illustrates how social media can amplify historical corporate decisions into current crises, forcing companies to address past actions that may have been legally permissible but socially damaging. The company’s decision to invest in mental health support may set a precedent for other brands facing similar scrutiny, though the lack of specific details in the announcement leaves the long-term impact uncertain.

What to watch

Neutrogena has promised to provide more details about its investment in a community health partner once plans are finalized. The company will likely face continued scrutiny from consumers and activists who are skeptical of the apology’s sincerity, given the delay in responding. The outcome of the investigation into Panettiere’s death, which the DEA is reportedly involved in, may also influence public perception of the brand’s response. Further developments in the boycott campaign and any legal or regulatory actions related to the brand’s treatment of mental health disclosures will determine the long-term impact on Neutrogena’s reputation.